Injective news and updates can now be accessed by millions of users on Crypto.com. This was achieved through our RSS feed integration with Crypto.com.
This announcement follows the listing of INJ on Crypto.com. As a major player in the cryptocurrency industry, Crypto.com’s listing makes it easy for users to trade INJ tokens at true cost with USD, EUR, GBP and over 20+ fiat currencies.
In addition to INJ, there are currently over 100 crypto assets that are listed on Crypto.com App and available for trading. To facilitate cryptocurrency transactions, Crypto.com Visa Cards enable users to easily convert INJ and other cryptocurrencies into fiat, which can then be spent at merchants worldwide.
Founded in 2016, Crypto.com today serves over 10 million customers with the world’s fastest growing crypto app, along with the Crypto.com Visa Card — the world’s largest crypto card program — the Crypto.com Exchange and Crypto.com DeFi Wallet. Recently launched, Crypto.com NFT is the premier platform for collecting and trading NFTs, carefully curated from the worlds of art, design, entertainment and sports. Its crypto ecosystem consists of the Crypto.com App,Crypto.com Exchange, Crypto.com DeFi Wallet, DeFi Swap, Crypto.com Visa Cards,Crypto Earn,Crypto Credit, Price Page, NFT marketplace, Ethereum Gas Fees Tracker, and many other services.
Crypto.com is built on a solid foundation of security, privacy and compliance and is the first cryptocurrency company in the world to have ISO/IEC 27701:2019, CCSS Level 3, ISO27001:2013 and PCI:DSS 3.2.1, Level 1 compliance, and independently assessed at Tier 4, the highest level for both NIST Cybersecurity and Privacy Frameworks.
Crypto.com is headquartered in Hong Kong with a 1,000+ strong team. Find out more by visiting https://crypto.com.
About Injective Protocol
Injective Protocol is the first layer-2 decentralized exchange protocol that unlocks the full potential of decentralized derivatives and borderless DeFi. Injective Protocol enables fully decentralized trading without any restrictions, allowing individuals to trade on any derivative market of their choosing. Injective is backed by a prominent group of stakeholders including Mark Cuban, Pantera Capital and Binance.